These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32984147)

  • 21. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloimmunization in transfused patients with constitutional anemias in Norway.
    Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
    Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloimmunization following antigen-negative red blood cell transfusion.
    Jacobs JW; Binns TC; Abels E; Iyer K; Figueroa Villalba CA; Verma A; Sostin N; Tormey CA
    Transfusion; 2023 Feb; 63(2):430-434. PubMed ID: 36458330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloimmunization among transfusion-dependent thalassemia patients.
    Sadeghian MH; Keramati MR; Badiei Z; Ravarian M; Ayatollahi H; Rafatpanah H; Daluei MK
    Asian J Transfus Sci; 2009 Jul; 3(2):95-8. PubMed ID: 20808654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients.
    Davari K; Soltanpour MS
    Asian J Transfus Sci; 2016; 10(1):88-92. PubMed ID: 27011679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red cell alloimmunization in repeatedly transfused patients.
    Bhuva DK; Vachhani JH
    Asian J Transfus Sci; 2017; 11(2):115-120. PubMed ID: 28970677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red Blood Cell Immunization and Contributing Factors in 685 Thalassemia Patients.
    Shaiegan M; Moghaddam M; Maghsudlu M; Azarkeivan A; Zolfaghari S; Pourfatollah AA; Soleimanzadeh P; Shahverdi E
    Int J Hematol Oncol Stem Cell Res; 2022 Jan; 16(1):9-14. PubMed ID: 35975116
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation.
    Uzuni A; El-Bashir J; Galusca D; Yeddula S; Nagai S; Yoshida A; Abouljoud MS; Otrock ZK
    Vox Sang; 2022 Mar; 117(3):408-414. PubMed ID: 34387366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of Frequency and Characteristics of Red Blood Cell Alloimmunization in Thalassemic Patients: Multicenter Study from Palestine.
    Abu Taha A; Yaseen A; Suleiman S; Abu Zenah O; Ali H; Abu Seir R; Younis K
    Adv Hematol; 2019; 2019():3295786. PubMed ID: 31781225
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients.
    Ahmed AM; Hasan NS; Ragab SH; Habib SA; Emara NA; Aly AA
    Arch Med Sci; 2010 Aug; 6(4):592-8. PubMed ID: 22371805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine.
    Samarah F; Srour MA; Yaseen D; Dumaidi K
    Adv Hematol; 2018; 2018():5356245. PubMed ID: 29977298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions.
    Waldis SJ; Uter S; Kavitsky D; Flickinger C; Vege S; Friedman DF; Westhoff CM; Chou ST
    Blood Adv; 2021 Feb; 5(3):737-744. PubMed ID: 33560383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.
    Pahuja S; Pujani M; Gupta SK; Chandra J; Jain M
    Hematology; 2010 Jun; 15(3):174-7. PubMed ID: 20557678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.
    Pessoni LL; Ferreira MA; Silva JCRD; Alcântara KC
    Hematol Transfus Cell Ther; 2018; 40(4):326-331. PubMed ID: 30370410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.
    Chaudhari CN
    Med J Armed Forces India; 2011 Jan; 67(1):34-7. PubMed ID: 27365758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of irregular red cell antibody in transfusion recipients vis-a-vis healthy blood donors attending a tertiary care hospital in North India.
    Yadav A; Raturi G; Aparna B
    Asian J Transfus Sci; 2022; 16(1):73-77. PubMed ID: 36199405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.